Overview

Efficacy, Tolerability, Safety, and Pharmacokinetic Study of DFN-15

Status:
Completed
Trial end date:
2018-08-20
Target enrollment:
Participant gender:
Summary
Efficacy, Tolerability, Safety and Pharmacokinetic Study of DFN-15 in Post-Surgical Dental Pain.
Phase:
Phase 2
Details
Lead Sponsor:
Dr. Reddy's Laboratories Limited
Treatments:
Celecoxib
Pharmaceutical Solutions